FDA cleared the Profoject™ Safe Push Button Blood Collection Sets from CMT Health PTE., Ltd. on Oct 28, 2026 under K262242, a traditional 510(k). The device falls under product code JKA, Tubes, Vials, Systems, Serum Separators, Blood Collection, regulated at 21 CFR 862.1675 as a Class 2 device. The review panel was Clinical Chemistry.

FDA logged the submission as received on Jul 1, 2026. The decision came 119 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

CMT Health PTE., Ltd. has 8 other decisions in the tracker over the last 12 months: K261372 (Profoject™ LOR Syringe), K262215 (Profoject™ Safety Sliding Blood Collection Set), K261829 (Profoject™ Dual-Safety Pen Needles), K260739 (Profoject™ Pen Needles (Model A; Model B)).